Beta 3-adrenoceptor stimulation induces vasorelaxation mediated essentially by endothelium-derived nitric oxide in rat thoracic aorta

被引:148
作者
Trochu, JN
Leblais, V
Rautureau, Y
Bévérelli, F
Le Marec, H
Berdeaux, A
Gauthier, C
机构
[1] CHU Nantes, INSERM CJF 96 01, Lab Physiopathol & Pharmacol Cellulaires & Mol, Nantes, France
[2] Fac Med Paris Sud, Dept Pharmacol, F-94276 Le Kremlin Bicetre, France
[3] Univ Nantes, Fac Sci & Tech, Nantes, France
关键词
rat thoracic aorta; relaxation; beta(3)-adrenoceptor; endothelium; nitric oxide; cyclic GMP;
D O I
10.1038/sj.bjp.0702797
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The relaxant effects of isoprenaline may result from activation of another beta-adrenoceptor subtype in addition to beta(1) and beta(2). This study evaluated the role of a third beta-adrenoceptor subtype, beta(3), in beta-adrenoceptor-induced relaxation of rat thoracic aorta by isoprenaline. 2 Isoprenaline produced a concentration-dependent relaxation of phenylephrine pre-contracted rings of the thoracic aorta (pD(2) = 7.46 +/- 0.15; E-max = 85.9 +/- 3.4%), which was partially attenuated by endothelium removal (E-max = 66.5 +/- 6.3%) and administration of the nitric oxide (NO) synthase inhibitor, L-NG-monomethyl arginine (L-NMMA:) (E-max = 61.3 +/- 7.9%). 3 In the presence of nadolol, a beta(1)- and beta(2)-adrenoceptor antagonist, isoprenaline-induced relaxation persisted (E-max = 55.6 +/- 5.3%), but occurred at higher concentrations (pD(2) = 6.71 +/- 0.10) than in the absence of nadolol and lasted longer. 4 Similar relaxant effects were obtained with two beta(3)-adrenoceptor agonists: SR 58611 (a preferential beta(3)-adrenoceptor agonist), and CGP 12177 (a partial beta(3)-adrenoceptor with beta(1)- and beta(2)-adrenoceptor antagonistic properties). SR 58611 caused concentration-dependent relaxation (pD(2) = 5.24 +/- 0.07; E-max = 59.5 +/- 3.7%), which was not modified by pre-treatment with nadolol but antagonized by SR 59230A, a beta(3)-adrenoceptor antagonist. The relaxation induced by SR 58611 was associated with a 1.7 fold increase in tissue cyclic GMP content. 5 Both relaxation and the cyclic GMP increase induced by SR 58611 were greatly reduced by endothelium removal and in the presence of L-NMMA. 6 We conclude that in the rat thoracic aorta, beta(3)-adrenoceptors are mainly located on endothelial cells, and act in conjuction with beta(1)- and beta(2)-adrenoceptors to mediate relaxation through activation of an NO synthase pathway and subsequent increase in cyclic GMP levels.
引用
收藏
页码:69 / 76
页数:8
相关论文
共 43 条
[11]   Lipolytic effects of conventional beta 3-adrenoceptor agonists and of CGP 12,177 in rat and human fat cells: preliminary pharmacological evidence for a putative beta 4-adrenoceptor [J].
Galitzky, J ;
Langin, D ;
Verwaerde, P ;
Montastruc, JL ;
Lafontan, M ;
Berlan, M .
BRITISH JOURNAL OF PHARMACOLOGY, 1997, 122 (06) :1244-1250
[12]  
GALITZKY J, 1993, J PHARMACOL EXP THER, V266, P358
[13]   EFFECTS OF NG-NITRO-L-ARGININE METHYL-ESTER ON VASODILATOR RESPONSES TO ACETYLCHOLINE, 5'-N-ETHYLCARBOXAMIDOADENOSINE OR SALBUTAMOL IN CONSCIOUS RATS [J].
GARDINER, SM ;
KEMP, PA ;
BENNETT, T .
BRITISH JOURNAL OF PHARMACOLOGY, 1991, 103 (03) :1725-1732
[14]   Functional beta(3)-adrenoceptor in the human heart [J].
Gauthier, C ;
Tavernier, G ;
Charpentier, F ;
Langin, D ;
LeMarec, H .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (02) :556-562
[15]   The negative inotropic effect of β3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle [J].
Gauthier, C ;
Leblais, V ;
Kobzik, L ;
Trochu, JN ;
Khandoudi, N ;
Bril, A ;
Balligand, JL ;
Le Marec, H .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (07) :1377-1384
[16]  
GRANNEMAN JG, 1992, J PHARMACOL EXP THER, V261, P638
[17]   BETA-ADRENOCEPTOR AGONIST MEDIATED RELAXATION OF RAT ISOLATED RESISTANCE ARTERIES - A ROLE FOR THE ENDOTHELIUM AND NITRIC-OXIDE [J].
GRAVES, J ;
POSTON, L .
BRITISH JOURNAL OF PHARMACOLOGY, 1993, 108 (03) :631-637
[18]   NOVEL SIGNAL TRANSDUCTION PATHWAY MEDIATING ENDOTHELIUM-DEPENDENT BETA-ADRENOCEPTOR VASORELAXATION IN RAT THORACIC AORTA [J].
GRAY, DW ;
MARSHALL, I .
BRITISH JOURNAL OF PHARMACOLOGY, 1992, 107 (03) :684-690
[19]   Stereoselective action of (R*,R*)-(+/-)-methyl-4-[2-[2-hydroxy-2-(3-chlorophenyl)ethylamino]propyl]-phenoxyacetic acid (BRL37344) on beta-adrenoceptors and metabolic chiral inversion [J].
Ida, K ;
Hashimoto, K ;
Kamiya, M ;
Muto, S ;
Nakamura, Y ;
Kato, K ;
Mizota, M .
BIOCHEMICAL PHARMACOLOGY, 1996, 52 (10) :1521-1527
[20]   (-)-CGP 12177-induced increase of human atrial contraction through a putative third beta-adrenoceptor [J].
Kaumann, AJ .
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 117 (01) :93-98